Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 1053125, 10 pages
https://doi.org/10.1155/2017/1053125
Review Article

An Elevated Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Colorectal Cancer: A Meta-Analysis

Department of Chemotherapy and Radiotherapy, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, 109 Xueyuan West Road, Lucheng District, Wenzhou 325027, China

Correspondence should be addressed to Jian Wu; moc.361@1naijzzw

Received 2 November 2016; Accepted 2 April 2017; Published 26 April 2017

Academic Editor: Paola Gazzaniga

Copyright © 2017 Xuan-zhang Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. L. M. Coussens and Z. Werb, “Inflammation and cancer,” Nature, vol. 420, no. 6917, pp. 860–867, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. D. G. DeNardo and L. M. Coussens, “Inflammation and breast cancer. Balancing immune response: Crosstalk between adaptive and innate immune cells during breast cancer progression,” Breast Cancer Research, vol. 9, no. 4, p. 212, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. G. P. Dunn, L. J. Old, and R. D. Schreiber, “The immunobiology of cancer immunosurveillance and immunoediting,” Immunity, vol. 21, no. 2, pp. 137–148, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Elinav, R. Nowarski, C. A. Thaiss, B. Hu, C. Jin, and R. A. Flavell, “Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms,” Nature Reviews Cancer, vol. 13, no. 11, pp. 759–771, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Qiang, C. Liang, F. Xiao et al., “Prognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis,” OncoTargets and Therapy, vol. 9, pp. 869–876, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Krenn-Pilko, U. Langsenlehner, E. M. Thurner et al., “The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients,” British Journal of Cancer, vol. 110, no. 10, pp. 2524–2530, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. W. He, C. Yin, G. Guo et al., “Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer,” Medical Oncology (Northwood, London, England), vol. 30, no. 1, p. 439, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. W. J. Choi, M. C. Cleghorn, H. Jiang, T. D. Jackson, A. Okrainec, and F. A. Quereshy, “Preoperative neutrophil-to-lymphocyte ratio is a better prognostic serum biomarker than platelet-to-lymphocyte ratio in patients undergoing resection for nonmetastatic colorectal cancer,” Annals of Surgical Oncology, vol. 22 Supplement 3, pp. 603–613, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. Z. M. Li, Y. F. Peng, C. Z. Du, and J. Gu, “Colon cancer with unresectable synchronous metastases: the AAAP scoring system for predicting the outcome after primary tumour resection,” Colorectal Disease, vol. 18, no. 3, pp. 255–263, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. H. J. Son, J. W. Park, H. J. Chang et al., “Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer,” Annals of Surgical Oncology, vol. 20, no. 9, pp. 2908–2913, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Q. Ying, Q. W. Deng, B. S. He et al., “The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients,” Medical Oncology (Northwood, London, England), vol. 31, no. 12, p. 305, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Stang, “Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses,” European Journal of Epidemiology, vol. 25, no. 9, pp. 603–605, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. J. F. Tierney, L. A. Stewart, D. Ghersi, S. Burdett, and M. R. Sydes, “Practical methods for incorporating summary time-to-event data into meta-analysis,” Trials, vol. 8, no. 1, p. 16, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. C. H. Schmid, P. C. Stark, J. A. Berlin, P. Landais, and J. Lau, “Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors,” Journal of Clinical Epidemiology, vol. 57, no. 7, pp. 683–697, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Duval and R. Tweedie, “Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis,” Biometrics, vol. 56, no. 2, pp. 455–463, 2000. View at Publisher · View at Google Scholar
  17. B. Azab, F. Mohammad, N. Shah et al., “The value of the pretreatment neutrophil lymphocyte ratio vs. platelet lymphocyte ratio in predicting the long-term survival in colorectal cancer,” Cancer Biomarkers, vol. 14, no. 5, pp. 303–312, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Baranyai, M. Krzystanek, V. Josa et al., “The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer,” Thrombosis and Haemostasis, vol. 111, no. 3, pp. 483–490, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Carruthers, L. M. Tho, J. Brown, S. Kakumanu, E. McCartney, and A. C. McDonald, “Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer,” Colorectal Disease, vol. 14, no. 10, pp. e701–e707, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. H. C. Kwon, S. H. Kim, S. Y. Oh et al., “Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer,” Biomarkers, vol. 17, no. 3, pp. 216–222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Mori, Y. Toiyama, S. Saigusa et al., “Systemic analysis of predictive biomarkers for recurrence in colorectal cancer patients treated with curative surgery,” Digestive Diseases and Sciences, vol. 60, no. 8, pp. 2477–2487, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. C. P. Neal, V. Cairns, M. J. Jones et al., “Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases,” Medical Oncology (Northwood, London, England), vol. 32, no. 5, p. 144, 2015. View at Publisher · View at Google Scholar
  23. K. Neofytou, E. C. Smyth, A. Giakoustidis, A. Z. Khan, D. Cunningham, and S. Mudan, “Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor,” Medical Oncology (Northwood, London, England), vol. 31, no. 10, p. 239, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Ozawa, S. Ishihara, T. Nishikawa et al., “The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer,” International Journal of Colorectal Disease, vol. 30, no. 9, pp. 1165–1171, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. M. J. Proctor, D. S. Morrison, D. Talwar et al., “A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study,” European Journal of Cancer (Oxford, England : 1990), vol. 47, no. 17, pp. 2633–2641, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Song, W. Eo, and S. Lee, “Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients,” World Journal of Gastroenterology, vol. 21, no. 43, pp. 12410–12420, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. Q. Sun, X. N. Han, H. J. Wang et al., “Prognostic significance of preoperative fibrinogen in patients with colon cancer,” World Journal of Gastroenterology, vol. 20, no. 26, pp. 8583–8591, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Szkandera, M. Pichler, G. Absenger et al., “The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients,” American Journal of Surgery, vol. 208, no. 2, pp. 210–214, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. C. S. Roxburgh and D. C. McMillan, “Role of systemic inflammatory response in predicting survival in patients with primary operable cancer,” Future Oncology (London, England), vol. 6, no. 1, pp. 149–163, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Liang, J. Zhu, H. Jia et al., “Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy,” Oncotarget, vol. 7, no. 1, pp. 1014–1028, 2016. View at Publisher · View at Google Scholar
  31. S. A. Kono, L. E. Heasley, R. C. Doebele, and D. R. Camidge, “Adding to the mix: fibroblast growth factor and platelet-derived growth factor receptor pathways as targets in non-small cell lung cancer,” Current Cancer Drug Targets, vol. 12, no. 2, pp. 107–123, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. H. M. Verheul, K. Hoekman, F. Lupu et al., “Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas,” Clinical Cancer Research, vol. 6, no. 1, pp. 166–171, 2000. View at Google Scholar
  33. K. Suzuki, K. Aiura, M. Ueda, and M. Kitajima, “The influence of platelets on the promotion of invasion by tumor cells and inhibition by antiplatelet agents,” Pancreas, vol. 29, no. 2, pp. 132–140, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. J. S. Palumbo, K. E. Talmage, J. V. Massari et al., “Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells,” Blood, vol. 105, no. 1, pp. 178–185, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Nieswandt, M. Hafner, B. Echtenacher, and D. N. Männel, “Lysis of tumor cells by natural killer cells in mice is impeded by platelets,” Cancer Research, vol. 59, no. 6, pp. 1295–1300, 1999. View at Google Scholar
  36. J. Mikami, Y. Kurokawa, T. Takahashi et al., “Antitumor effect of antiplatelet agents in gastric cancer cells: an in vivo and in vitro study,” Gastric Cancer, vol. 19, no. 3, pp. 817–826, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. C. McCowan, A. J. Munro, P. T. Donnan, and R. J. Steele, “Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality,” European Journal of Cancer (Oxford, England : 1990), vol. 49, no. 5, pp. 1049–1057, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. A. T. Chan, S. Ogino, and C. S. Fuchs, “Aspirin use and survival after diagnosis of colorectal cancer,” Jama, vol. 302, no. 6, pp. 649–658, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. J. E. Niederhuber, “Cancer vaccines: the molecular basis for T cell killing of tumor cells,” The Oncologist, vol. 2, no. 5, pp. 280–283, 1997. View at Google Scholar
  40. W. S. Lee, S. Park, W. Y. Lee, S. H. Yun, and H. K. Chun, “Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer,” Cancer, vol. 116, no. 22, pp. 5188–5199, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. D. M. Frey, R. A. Droeser, C. T. Viehl et al., “High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients,” International Journal of Cancer, vol. 126, no. 11, pp. 2635–2643, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. M. J. Gooden, G. H. de Bock, N. Leffers, T. Daemen, and H. W. Nijman, “The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis,” British Journal of Cancer, vol. 105, no. 1, pp. 93–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. D. T. Le, J. N. Uram, H. Wang et al., “PD-1 blockade in tumors with mismatch-repair deficiency,” The New England Journal of Medicine, vol. 372, no. 26, pp. 2509–2520, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. C. H. Son, J. H. Bae, D. Y. Shin et al., “CTLA-4 blockade enhances antitumor immunity of intratumoral injection of immature dendritic cells into irradiated tumor in a mouse colon cancer model,” Journal of Immunotherapy, vol. 37, no. 1, pp. 1–7, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. X. Gu, X. S. Gao, S. Qin et al., “Elevated platelet to lymphocyte ratio is associated with poor survival outcomes in patients with colorectal cancer,” PloS One, vol. 11, no. 9, Article ID e0163523, 2016. View at Publisher · View at Google Scholar
  46. H. X. Peng, K. Lin, B. S. He et al., “Platelet-to-lymphocyte ratio could be a promising prognostic biomarker for survival of colorectal cancer: a systematic review and meta-analysis,” FEBS Open Bio, vol. 6, no. 7, pp. 742–750, 2016. View at Publisher · View at Google Scholar · View at Scopus